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In vivo studies of UVB effects on human skin are
precluded by ethical and technical arguments on vol-
unteers and inconceivable in cancer-prone patients
such as those affected with Xeroderma Pigmentosum
(XP). Establishing reliable models to address mecha-
nistic and therapeutic matters thus remains a chal-
lenge. Here we have used the skin-humanized mouse
system that circumvents most current model con-
straints. We assessed the UVB radiation effects includ-
ing the sequential changes after acute exposure with
respect to timing, dosage, and the relationship be-
tween dose and degree-sort of epidermal alteration.
On Caucasian-derived regenerated skins , UVB irra-
diation (800 J/m2) induced DNA damage (cyclobu-
tane pyrimidine dimers) and p53 expression in ex-
posed keratinocytes. Epidermal disorganization was
observed at higher doses. In contrast, in African de-
scent–derived regenerated skins, physiological hy-
perpigmentation prevented tissue alterations and
DNA photolesions. The acute UVB effects seen in Cau-
casian-derived engrafted skins were also blocked by a
physical sunscreen, demonstrating the suitability of
the system for photoprotection studies. We also re-
port the establishment of a photosensitive model
through the transplantation of XP-C patient cells as
part of a bioengineered skin. The inability of XP-C
engrafted skin to remove DNA damaged cells was
confirmed in vivo. Both the normal and XP-C ver-
sions of the skin-humanized mice proved proficient
models to assess UVB-mediated DNA repair re-
sponses and provide a strong platform to test novel
therapeutic strategies. (Am J Pathol 2010, 177:865–872;
DOI: 10.2353/ajpath.2010.091096)
Excessive exposure to solar UV radiation causes severe
acute damages to the skin, including erythema, sunburn,
immunosupression, and also long-term effects such as
photoaging and skin cancer.1–5 UV effects are greatly
exacerbated in patients suffering from Xeroderma Pig-
mentosum (XP), an autosomal and recessive disorder
characterized by a severe deficiency in the most versatile
DNA-repair mechanism in charge of the removal of bulky
DNA adducts including UV-induced cyclobutane pyrim-
idine dimmers (CPDs) and pyrimidine pyrimidone photo-
products (6-4PPs). The study of the in vivo biological
effects of UV irradiation on human volunteers is restricted
for ethical and technical reasons, namely frequency of
sampling and size of the skin biopsies and homogeneity
of samples. Different animal models have been used to
study the in vivo effects of UV light on the skin. However,
all of them present significant limitations. One of the most
widespread, the mouse model, weakens as a model to
study UV effects due to the differences between mouse
and human skin in terms of epidermal thickness/architec-
ture and DNA repair abilities. Mouse skin is far thinner
and hairier than human skin and in addition, global nu-
cleotide excision repair (G-NER), the most important DNA
repair mechanism acting in humans, appears less rele-
vant in mouse skin.6,7 To circumvent these restrictions,
models based on grafting human skin biopsies on to
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out in keratinocytes by retroviral infection with different
vectors expressing wild-type XP cDNAs as described.20
Primary Cultures of Normal and XP-C Human
Keratinocytes and Fibroblasts
Human keratinocytes and dermal fibroblasts were obtained
from skin biopsies of donors by enzymatic digestion.20 Pri-
mary keratinocytes were cultured on a feeder layer of le-
thally irradiated (X-ray; 50 Gy) 3T3-J2 cells (a gift from Dr
J. Garlick Tufts University) as previously described.22,23
The keratinocyte seeding media was a 3:1 mixture of
Dulbecco’s modified Eagle medium (DMEM) (GIBCO-
BRL, Barcelona, Spain) and HAM’S F12 containing
10% fetal calf serum replacement (Fetal Clone II, Hy-
clone-Lonza), 0.1 nmol/L cholera toxin, 2 nmol/L T3, 5
g per ml insulin, and 0.4 g per ml hydrocortisone.
Primary fibroblasts, obtained through collagenase digestion
after tripsinization of biopsies, were cultured in DMEM con-
taining 10% FCS. Cells were cultured at 37°C in a humid
atmosphere containing 5% CO2. The culture medium was
changed every 2 days.
Bioengineered Skin Preparation and Grafting to
Immunodeficient Mice
The bioengineered human skin equivalent is based on
the use of a fibrin matrix containing live fibroblasts (either
normal or XP-C) as a dermal component.22,23 Briefly, 3 ml
of the fibrinogen (from cryoprecipitates) was added to 12
ml of DMEM with 10% FCS containing 5  105 dermal
fibroblasts and 500 IU of bovine aprotinin (Trasylol;
Bayer, West Haven, CT). Immediately afterward, 1 ml of
0.025 mmol/L CaCl2 (Sigma, St. Louis, MO) with 11 IU of
bovine thrombin (Sigma) was added. Finally, the mixture
was placed on a six-well culture plate (Transwell; Costar,
Cambridge, MA) and allowed to solidify at 37°C for 2
hours. Normal or XP-C keratinocytes were then seeded
and grown submerged up to keratinocyte confluence.
Immunodeficient nu/nu female mice (NMRI strain; El-
evage-Janvier, France) were aseptically cleansed and
grafted as previously described elsewhere.14,22 Briefly,
full thickness 12-mm circular wounds were then created
on the dorsum of the mice. Bioengineered equivalents
were placed orthotopically on the wound and covered
with devitalized mouse skin. Mice were housed for the
duration of the experiment at the CIEMAT Laboratory
Animals Facility (Spanish registration number 28079–21
A) in pathogen-free conditions using individually ven-
tilated type II cages (25 air changes per hour) and 10
KGy-irradiated soft wood pellets as bedding.
UV Irradiations of Skin-Humanized Mice
The UVB source was two fluorescent sunlamps (Philips,
UVB TL20W/12RS), with peak at 312 nm (UV in the B
range, 290 to 320 nm). The wavelength was carefully
determined with a spectroradiometer (UVX radiometer,
UVP Inc., Upland, CA). The UVB irradiance was 2.0 mw/
immunodeficient mice have been developed to study 
UVB-induced effects.6,8 These systems are a useful way 
to combine the human native skin organization with the 
corresponding preservation of its typical human DNA 
lesion repair mechanisms. In addition, human skin biop-
sies grafted to immunodeficient mice have also been 
shown to be of value to study UVB-induced carcinogen-
esis.9–11 However, these approaches are again limited 
for ethical and technical constraints. Under such an ex-
perimental setting, each skin biopsy from a volunteer is 
used to generate a single grafted mouse. Thus, the pos-
sibility to perform a large study in a homogenous popu-
lation is hampered. It is worth mentioning that neither the 
former nor other kind of humanized in vivo models have 
been reported for XP patients. An alternative to whole 
skin biopsy grafting is to achieve human skin regenera-
tion on mice on engraftment of tissue-engineered skin 
equivalents. This approach offers the unique opportunity 
to generate animals engrafted with identical skin sam-
ples. In fact, only one skin biopsy donation may suffice to 
generate a big surface of bioengineered skin constructs, 
enabling in turn the production of a large number of 
skin-humanized mice.12 A new skin-humanized mouse 
model based on the grafting of a skin equivalent, previ-
ously used in clinics for permanent skin regeneration in 
burn patients,13,14 was recently shown to be a suitable 
model for the study of physiological processes such as 
wound healing in a human context.15,16 Moreover, the 
platform allows trustworthy and efficient modeling and 
gene therapy of inherited skin diseases such as differ-
ent forms of Epidermolysis Bullosa.17–19 These results 
prompted us to test the performance of our model to study 
the effects of UV under normal skin conditions and to seek 
a new UV hypersensitive model.
In the present work we characterized the in vivo bio-
logical acute effects of UV irradiation on the skin-human-
ized mouse model by assessing the histopathological 
changes elicited at different doses. Changes including 
epidermal architecture alterations, increased keratino-
cyte proliferation, and DNA damage were analyzed. In 
addition, we report the development and characterization 
of a photosensitive XP-C skin-humanized mouse model, a 
suitable platform to gain new insight on UVB biological 
effects and DNA repair–dependent pathogenesis and to 
test novel therapeutic approaches for this rare cancer-
prone inherited disease.
Materials and Methods
Normal and XP-C Skin Samples
All human skin samples were donated with informed con-
sent and with the approval of the Hospital Clinic de 
Barcelona ethics committee. Normal human foreskin 
samples were obtained from phimosis/circumcision sur-
gery from Caucasian and black (African-descent) 0- to 
1-year-old donors. Skin biopsies of XP-C were obtained 
from two different patients from nonlesional skin areas. 
Determination of XP complementation group was carried
2
cm2. UVB irradiation (single dose) was performed on
stable engrafted mice (9–12 weeks post grafting). Bio-
logical efficient UV dose (BED) was determined through
irradiation of Caucasian-derived cell engrafted mice at
different doses ranging from 400 to 1200 J/m2.6,24 In our
setting, the UV dose giving rise to sunburn cells 24 hours
after irradiation (1 BED) was established at 800 J/m2. For
photoprotection analysis, human engrafted skin was top-
ically treated with sunscreen cream (SPF-90, ISDIN, Bar-
celona) (2 mg/cm2). Animals were irradiated 30 minutes
after sunscreen application.
Histopathological Analysis of UV Exposed
Human Skin
Control or UV-irradiated mice were sacrificed by CO2
inhalation. Tissue samples (2 mm biopsy punches
(STIEFEL LAB, Madrid, Spain) of each engrafted mouse
were collected at different time points after UV exposure.
Skin samples were harvested and fixed in 3.7% buffered
formaldehyde. After fixation the skin biopsy was embed-
ded in paraffin. Serial 4-m cross-sections were ob-
tained. The UV-irradiated human skin (normal and XP-C)
was analyzed by histological and immunohistochemical
techniques. Paraffin sections were dewaxed and rehy-
drated in water solutions containing decreasing percent-
ages of ethanol. To determine tissue architecture and
detect sunburn cells, sections were stained with hema-
toxylin–eosin (Gill 2 Hematoxylin and Eosin Y alcoholic;
Thermo Shandon, Cheshire, UK) following a standard
procedure. The human origin of the grafts was deter-
mined by immunostaining using a human specific anti-
involucrin monoclonal antibody (clone SY-5, Sigma) that
decorated the regenerated human skin but not the mouse
skin, as previously described.14,15,22 The human epider-
mal-associated proliferative marker keratin K6 was la-
beled with LHK6B monoclonal antibody (NeoMarkers.
CA). Immunofluorescent detection was performed using
keratin K5 (Covance), and Proliferating Cell Nuclear An-
tigen (PCNA) (Thermo Scientific) antibodies.
To evaluate the DNA damage induced by UVB we
used mouse monoclonal antibodies against CPDs at final
dilution 1:1000 (H3 clone 4F6, Afitech) and p53 (clone
DO-7, Dako) at final dilution 1:20. To assess epidermal
cell proliferation before and after UV irradiation, grafted
mice were IP injected with 20 mg per kg of BrdU 1 hour
before euthanasia. BrdU immunodetection was per-
formed using specific antibodies against BrdU (Roche,
IN) at a 1:50 dilution. Immunoperoxidase staining was
developed using the Vectastain ABC kit (Vector, Burlin-
game, CA).
Statistical Analysis
A Student’s t-test was applied to compare the means of
samples using Microsoft Excel (Microsoft, Redwood,
CA). Differences were considered statistically significant
when P  0.05.
Results
Acute UVB Responses on Normal
Skin-Humanized Mice
The performance of the skin-humanized mice to acute
UVB irradiation effects was assessed on mice engrafted
after transplantation of bioengineered skin equivalents
containing normal human epidermal cells (including res-
ident melanocytes) from either Caucasian or African do-
nors of identical age and location source (ie, foreskin)
(Figure 1A). Despite the large macro and microscopic
pigmentation differences, the histological features of both
human engrafted skins were very similar in terms of thick-
ness, differentiated strata number, and stratum corneum
maturation (Figure 1, B and C).
A UVB BED, measured as the minimal dose inducing
histological sunburn cells (SBC),6,23 was first determined
in dose response experiments performed on nonpig-
mented skin-humanized mice. In our setting, a 800 J/m2
dose of UVB was established as 1 BED (see Materials
and Methods).
Twenty four hours after exposure to a sub BED dose
(0.5 BED) of UVB, a marked differential response be-
tween Caucasian and African donor-derived skins was
observed. In fact, nonpigmented skin reacted by thick-
ening and concomitant induction of the hyperprolifera-
Figure 1. Macro and microscopic appearance of Caucasian and African
descent-derived regenerated skins. A: Phenotypical appearance of mice
engrafted with skin regenerated either from Caucasian (right) or African
descent-derived (left) keratinocytes (including melanocytes) and fibroblasts.
Grafts are delimited by dotted lines. B: Histological appearance (H&E
staining) of Caucasian donor-derived regenerated skin 12 weeks after graft-
ing. C: Histological appearance (H&E staining) of African descent-derived
regenerated skin 12 weeks after grafting. Note the brownish color due to
(unstained) melanin in the basal cell compartment. Scale bar  100 m.
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tion-associated keratin K6 (Figure 2, E and F) as com-
pared with nonirradiated skin (Figure 2, A, B, and M). By
contrast, pigmented skin appeared to be completely inert
both in terms of acanthotic and keratin K6 induction
responses (Figure 2, C, D, G, H, and M). It is worth noting
that, as predicted, a 0.5 BED dose was unable to induce
either SBC or CPD in the nuclei of exposed keratinocytes
(see below). Forty-eight hours after 0.5 BED irradiation,
epidermal acanthosis was still present in Caucasian-de-
rived skin but quantitative data showed a slight, although
not statistically significant, decline. Persistence of epider-
mal thickening 48 hours after irradiation was accompa-
nied by concomitant maintenance of keratin K6 expres-
sion (Figure 2, I and J). In contrast to Caucasian-derived
skin, hyperpigmented skin remained unaffected (Figure
2, K and L).
The protective action of high melanin content in re-
generated skins was evaluated 24 hours after a supra
BED (4 BED). In contrast to that found at 0.5 BED
(Figure 2) or 1 BED (Figure 3A) doses, Caucasian
donor–derived regenerated skins underwent an impor-
tant tissue damage characterized by keratinocyte spon-
giosis, abundant SBC, and epidermal blistering (Figure
3C). By contrast, African descent donor–derived skin
irradiated with 4 BED preserved its normal epidermal
architecture despite the presence of SBC (Figure 3D) as
compared with the unaffected, 1 BED–irradiated skin
(Figure 3B). This result indicates that the high pigmenta-
tion confers, semiquantitatively, a fourfold protection from
the acute effects of UVB. In other words, in our setting, a
4 BED for Caucasian donor–derived skin represents
nearly 1 BED for pigmented skin. Noteworthy, skin archi-
tecture was preserved in pigmented skin even at a 8 BED
(data not shown).
To assess the suitability of the system for photoprotec-
tion studies, we also tested the efficacy of a strong phys-
ical sunscreen (SPF 90) on Caucasian donor–derived
skin engrafted mice. Topical application of the product
30 minutes before a 4 BED dose completely blocked the
effects of UVB including the hyperplastic nongenotoxic
ones seen at a sub BED (0.5 BED) dose (Figure 3E and
data not shown).
Figure 2. Histopathological changes after low-dose (0.5 BED) UVB irradiation in skin humanized mice A–D: Histological sections of regenerated human skins
taken immediately before 0.5 BED of UVB irradiation. A and C: Hematoxylin-eosin (H&E) staining. B and D: Immunoperoxidase staining of keratin K6. E–H:
Histological sections of regenerated human skins taken 24 hours after 0.5 BED. E and G: H&E staining. F and H: Keratin K6 immunoperoxidase staining. Note
the acanthosis (thickening) and K6-positive staining of Caucasian-derived skin (E and F, respectively). I–L: Histological sections of regenerated human skin taken
48 hours after 0.5 BED. I and K: H&E staining. J and L: Keratin K6 immunoperoxidase staining. Panels A, B, E, F, I, and J correspond to Caucasian-derived
regenerated skin. Panels C, D, G, H, K, and L correspond to African descent-derived regenerated skins. Scale bar 100 m. M: Quantitative analysis of epidermal
thickness at 24 and 48 hours after irradiation. Open bars indicate Caucasian-derived skins; shaded bars, African-derived skins. Scale bar  100 m. **P  0.01.
Figure 3. Histopathological changes after high-dose (4 BED) UVB irradia-
tion in Caucasian, African descent-derived, and photoprotected (Caucasian)
regenerated skins. A: Histological appearance (H&E staining) of a represen-
tative section of 1 BED irradiated Caucasian-derived skin 24 hours after
irradiation. B: Histological appearance of a representative section of 1 BED
irradiated African descent-derived skin 24 hours after irradiation. C: Histo-
logical appearance (H&E staining) of a representative section of 4 BED-
irradiated Caucasian-derived skin 24 hours after irradiation. Note the disrup-
tion of the epidermal architecture. D: Histological appearance (H&E staining)
of a representative section of 4 BED-irradiated African descent-derived skin
24 hours after irradiation. Arrows indicate sunburn cells. E: Histological
appearance (H&E staining) of a representative section of a photoprotected
(SPF 90), UVB-irradiated (4 BED) Caucasian-derived skin 24 hours after
irradiation. Note the absence of acanthosis, epidermolysis, and sunburn cells.
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Both the hyperplastic and SBC biological responses
have a molecular correlate at the DNA level as an in-
crease of BrdU-labeled nuclei and the induction of single
DNA strand breaks measured as CPD, respectively. The
kinetics of BrdU changes were analyzed by immunoper-
oxidase in both Caucasian and African descent donor–
engrafted skins irradiated with 0.5 BED. As expected,
nonirradiated quiescent regenerated human skin showed
few BrdU labeled nuclei (Figure 4A). Consistent with the
epidermal thickening observed at 0.5 BED in Caucasian-
derived skins (Figure 2), a fivefold increase of BrdU-
labeled nuclei was found (4.4  1.5 versus 22.07  8.02
labeled nuclei per field) 24 hours post irradiation (Figure
4B). In contrast, as expected from the absence of acan-
thosis, African descent donor–derived grafts showed no
increase in proliferating cells (2.2  1.4 versus 1.4  0.8
labeled nuclei per field). Ninety-six hours after irradiation,
the hyperproliferative response in Caucasian donor–de-
rived skin remained high but attenuated respect to that
observed at 24 hours (12  2.9 versus 22.07  1.4
labeled nuclei per field) (Figure 4C) and maintained at
control levels in hyperpigmented grafts (Figure 4D).
To better characterize the proliferating cell population
we performed a double immunofluorescence analysis of
PCNA and keratin K5, a marker of basal epidermal cells,
24 hours after a 0.5 BED irradiation. Consistent with the
BrdU immunoperoxidase data, PCNA nuclear labeling
was very robust in Caucasian donor–derived skins but
comparable to that of unirradiated skin in hyperpig-
mented grafts. In both graft types, PCNA-positive nuclei
colocalized exclusively with K5-labeled cells (Figure 4, E
and F). At 0.5 BED no immunoreaction to CPD was de-
tected at any time point indicating that DNA damage was
either low or absent. (data not shown).
Analysis performed in Caucasian skin grafts 24 hours
after 1 BED irradiation showed a remarkably low BrdU
incorporation (Figure 5, A and B). However, 96 hours post
irradiation a robust delayed proliferative response and
concomitant hyperplasia was observed (Figure 5C). By
contrast, in hyperpigmented skins, BrdU incorporation
remained at control levels (nonirradiated skin) at both
time points (Figure 5A), suggesting that a threshold dose
capable to induce the hyperproliferative response, seen
at 0.5 BED in Caucasian skins, was not reached.
Figure 4. Kinetic analysis of epidermal cell proliferation (BrdU incorpora-
tion) after 0.5 BED of UVB. A: BrdU staining of nonirradiated human (Cau-
casian) regenerated skin. B: BrdU staining of 0.5 BED-irradiated human
(Caucasian) regenerated skin 24 hours after irradiation. C: BrdU staining of
0.5 BED-irradiated human (Caucasian) regenerated skin 96 hours after irra-
diation. Scale bar  100 m. D: Quantitative analysis of BrdU incorporation
24 hours and 96 hours after 0.5 BED irradiation. Open bars: Caucasian-
derived skins. Shaded bars: African-derived skins. *P  0.05; **P  0.01.
E and F: Double immunofluorescence staining for Keratin K5 (green) and
PCNA (red) in Caucasian (E) and African (F)-derived skins 24 hours after 0.5
BED irradiation. Nuclei are counterstained with DAPI (blue).
Figure 5. Kinetic analysis of epidermal cell proliferation (BrdU incorpora-
tion) and DNA damage (CPD) after 1 BED of UVB. A: Quantitative analysis
of BrdU incorporation 24 hours and 96 hours after 1 BED irradiation. Open
bars: Caucasian-derived skins. Shaded bars: African-derived skins. **P 0.01.
B: BrdU staining of 1 BED-irradiated human (Caucasian) regenerated skin 24
hours after irradiation. Note the absence of BrdU labeling. C: BrdU staining
of 1 BED-irradiated human regenerated skin (Caucasian) 96 hours after
irradiation. D: CPD immunostaining of 1 BED-irradiated human regenerated
skin 24 hours after irradiation. E: CPD immunostaining of 1 BED-irradiated
human regenerated skin (Caucasian) 96 hours after irradiation. Note the
strong positive staining of heavily damaged cells in their transit to desqua-
mation. F: p53 immunostaining of 1 BED-irradiated human regenerated skin
24 hours after irradiation. G: p53 immunostaining of 1 BED-irradiated human
regenerated skin 96 hours after irradiation. Dotted lines depict the epider-
mal-dermal border.
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The differential proliferative response between 0.5 and
1 BED doses seen 24 hours after irradiation in Caucasian
skins is clearly explained by the fact that at 1 BED, almost
all epidermal nuclei were labeled for CPD (Figure 5D)
and p53 (Figure 5F). In contrast to the extinction of the
hyperproliferative response seen 96 hours after a 0.5
BED, a reactive hyperproliferation burst appears to be
required, after 1 BED, to trigger an accelerated differen-
tiation and desquamation process to rapidly eliminate
those heavily DNA-damaged cells. In fact, 96 hours after
irradiation CPD-labeled cells were pictured only at a
highly suprabasal location in their transit to desquama-
tion (Figure 5E). The fact that neither basal nor early
suprabasal cells maintained detectable CPD indicates
that efficient DNA repair has occurred within the pro-
liferative cell compartment allowing a proliferative re-
start (Figure 5C). Consistently, no p53-positive cells
were detected at this time point (Figure 5G). These
results confirms previous findings obtained in vitro on
skin equivalents.25
Development of a XP-C Skin-Humanized
Mouse Model and Assessment of Acute
UVB Responses
Previous work from our laboratory focused on the devel-
opment of trustworthy in vivo models for inherited skin
diseases to test novel therapeutic approaches including
gene therapy.12,17–19 Those results prompted us to seek
for a humanized in vivo model for the photosensitive and
cancer-prone disease XP. To that end, keratinocytes and
fibroblasts from nonlesional areas of two different pa-
tients (Figure 6A) suffering from XP-C, the most common
form of XP, were cultured, assembled in tissue-engi-
neered skin equivalents, and grafted to immunodeficient
mice. As with normal and other genodermatosis-derived
cells, skin regeneration occurred efficiently allowing the
generation of a number of XP-C skin-engrafted animals.
Engrafted animals maintained stable grafts up to 22
weeks, the longest time assessed. This result indicated
that in vitro manipulation involving cell culture and skin
bioengineering did not affect the regenerative capacity of
XP-C cells, which requires the presence and persistence
of epidermal stem cells. Engrafted animals presented
hyperpigmented skin (Figure 6C), a common feature
seen also in XP-C patients (Figure 6A). Twelve weeks
after grafting, mature XP-C skin regenerated on mice
(Figure 6D) was histologically equivalent to that of donor
skin biopsy showing no apparent phenotypic alterations
(Figure 6B).
Once the model was established, we tested the acute
responses to UVB and, considering the deficiency of XP
keratinocytes in nucleotide excision repair, we concen-
trated on assessing the presumably functional inability of
XP-C engrafted skin to remove the DNA-damaged cells
as previously shown in vitro.26 Given the hyperpigmented
nature of XP-C engrafted skins, we used age-matched
African descent skin donor–derived engrafted mice as
controls. Accordingly, a 4 BED UVB dose was required to
achieve CPD induction. Kinetics of CPD induction and
clearance were determined 2 hours and 72 hours after
irradiation (Figure 7). Two hours after irradiation, both
control and XP-C grafts showed abundant CPD-labeled
nuclei distributed along different epidermal strata (Figure
7, A and C). Removal of damaged cells upwards (toward
desquamation) was evident at 72 hours only in control
(Figure 7B) skin but not in XP-C skins where CPD re-
mained in all epidermal strata (Figure 7D), demonstrating
the functional inability of human XP-C cells, for the first
time, in vivo. This result, which confirms previous findings
in a skin organotypic system,26 suggests the suitability of
Figure 6. Development of a XP-C skin-humanized mouse model. A: Phys-
ical characteristic appearance of one of the XP-C donor patients. B: Histo-
logical appearance (H&E staining) of a section from the patient’s skin biopsy
used to culture skin cells. C: Appearance of a representative XP-C regener-
ated skin-engrafted mouse. Note that cells from patient 1 (shown in A) give
rise to pigmented regenerated skin. D: Histological appearance (H&E stain-
ing) of a section of the regenerated human skin in a mouse engrafted with
cells from patient in A.
Figure 7. In vivo inability to repair DNA damage (CPD) in XP-C regenerated
skin. A: CPD immunostaining of 4 BED-irradiated normal African-derived
skin (control) section two hours after irradiation. B: CPD immunostaining of
4 BED-irradiated control skin section 72 hours after irradiation. C: CPD
immunostaining of 4 BED-irradiated XP-C regenerated skin section 2 hours
after irradiation. D: CPD immunostaining of 4 BED-irradiated XP-C regener-
ated skin section 72 hours after irradiation. Note the persistence of CPD-
labeled cells in all epidermal strata indicating a DNA damage repair defect.
Dotted lines depict the epidermal-dermal border. Scale bar  50 m.
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the XP-C skin-humanized model to test corrective ap-
proaches including ex vivo gene therapy.
Discussion
UV radiation is the main noxious and carcinogenic agent
for human skin. Molecular changes associated to UVB
irradiation have been extensively characterized in vitro in
keratinocytes in culture.27,28 Although highly informative,
these transcriptional profiling and other biochemical
analyses are somewhat skewed by the fact that cultured
keratinocytes represent only a mitotically activated basal
cell compartment. The presence of differentiated cell
layers of the epidermis achieved in 3D organotypic cul-
tures allows for more accurate in vitro models to study UV
effects. However, the organotypic systems often maintain
a (hyper)proliferative basal stratum as compared with
quiescent native human epidermis and only allow for
relatively short-term studies. Reliable in vivo studies lack
behind due to the ethical or practical constraints of using
human volunteers or inaccurate animal models. Our
group has developed a skin-humanized mouse platform
based on skin tissue engineering and optimized surgical
procedures in immunodeficient hosts enabling long-term
human skin regeneration as well as skin disease model-
ing and therapeutic approaches.12
In this work we assessed the performance of our model
in the acute UVB effects in vivo. By using Caucasian or
African-descent donor keratinocytes we were able to re-
generate differentially pigmented skins without the need
of adding exogenous melanocytes to the system as in
other tissue engineered-based models.29,30 In fact, our
system relies on the persistence of resident melanocytes
during short-term keratinocyte culture on lethally irradi-
ated feeder layers.21 Under such conditions, cultures
usually maintain their physiological 1:40 (melanocytes:
keratinocytes) ratio, which is preserved also in graftable
skin equivalents and regenerated skins.31,32 We were
able to characterize dose-dependent nongenotoxic and
DNA damaging UVB responses and their modulation by
the degree of skin pigmentation. Our in vivo study con-
firms and extends previous results establishing a photo-
protective effect of supranuclear melanin caps in native
human skin explants.33 By using the appearance of sun-
burn cells as a histological marker of UVB genotoxic
effects, we were also able to establish a nearly fourfold
photoprotective factor of high melanin content as found
for phototype VI skins.33,34 The model also proved satis-
factory to test topic photoprotective agents as well as
DNA damage repair kinetics after UVB irradiation. In fact,
the physiological epidermal turnover and differentiation
allowed the identification of CPD-containing cells in their
transit to desquamation. While studies on the acute UVB
effects in volunteers and human skin xenografts showed
results similar to ours in terms of epidermal hyperplasia
and keratin K6 induction,6,35 minor differences in the
acanthotic response kinetics were noticed. It is likely that
such discrepancies are the consequence of fine tuning
variations in the MED/BED estimation in each particular
experimental setting. In this regard, it is noteworthy that
remarkable differences have been observed between 0.5
and 1 BED in terms of functional epidermal cell prolifer-
ation kinetics.
In addition to the studies in normal regenerated human
skin, a major goal was the establishment of an in vivo
photosensitive skin humanized mouse model. That was
achieved through the efficient engraftment of bioengi-
neered skin equivalents composed of XP-C patient-de-
rived keratinocytes and fibroblasts. The human XP-C re-
generated skin allowed assessing the persistence of
UVB-induced DNA damage for the first time in vivo. Our
findings of CPD persistence recapitulated those previ-
ously described using XP-C organotypic skin cultures.26
However, in contrast to in vitro systems only reliable to
assess acute short-lasting UVB effects, our XP-C model
appears suitable to study chronic effects including mu-
tagenesis and carcinogenesis, which require clonal ex-
pansion of damaged/initiated stem cells. Permanent skin
regeneration involving stem cell preservation is also a
requisite to test long-lasting therapeutic approaches
such as gene therapy. As previously achieved using
clinically relevant humanized in vivo models for dystro-
phic and junctional forms of Epidermolysis Bullosa,17,19
our new XP-C model certainly warrants testing ex vivo
cutaneous gene therapy approaches for XP-C. Overall,
our normal and XP-C skin-humanized models constitute
valuable proxy tools (to avoid the use of human subjects)
for research in the pathogenesis and therapeutics of
UV-induced lesions.
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